Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial

被引:40
作者
Williams, NH
Edwards, RT
Linck, P
Muntz, R
Hibbs, R
Wilkinson, C
Russell, I
Russell, D
Hounsome, B
机构
[1] Cardiff Univ, Wales Coll Med, Dept Gen Practice, Wrecsam LL13 7YP, Wales
[2] CAPRICORN, Wrecsam, Wales
[3] Univ Wales Bangor, Inst Med & Social Care Res, Ctr Econ Hlth, Bangor, Gwynedd, Wales
关键词
back pain; cost-utility; neck pain; osteopathy; primary care; QALY;
D O I
10.1093/fampra/cmh612
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Spinal pain is common and costly to health services and society. Management guidelines have encouraged primary care referral for spinal manipulation, but the evidence base is weak. More economic evaluations alongside pragmatic trials have been recommended. Objective. Our aim was to assess the cost-utility of a practice-based osteopathy clinic for subacute spinal pain. Methods. A cost-utility analysis was performed alongside a pragmatic single-centre randomized controlled trial in a primary care osteopathy clinic accepting referrals from 14 neighbouring practices in North West Wales. Patients with back pain of 2-12 weeks duration were randomly allocated to treatment with osteopathy plus usual GP care or usual GP care alone. Costs were measured from a National Health Service (NHS) perspective. All primary and secondary health care interventions recorded in GP notes were collected for the study period. We calculated quality adjusted life year (QALY) gains based on EQ-5D responses from patients in the trial, and then cost per QALY ratios. Confidence intervals (CIs) were estimated using non-parametric bootstrapping. Results. Osteopathy plus usual GP care was more effective but resulted in more health care costs than usual GP care alone. The point estimate of the incremental cost per QALY ratio was pound3560 (80% CI pound542-pound77 100). Sensitivity analysis examining spine-related costs alone and total costs excluding outliers resulted in lower cost per QALY ratios. Conclusion. A primary care osteopathy clinic may be a cost-effective addition to usual GP care, but this conclusion was subject to considerable random error. Rigorous multi-centre studies are needed to assess the generalizability of this approach.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 50 条
[21]   Cost-utility of collaborative care for major depressive disorder in primary care in the Netherlands [J].
Goorden, Maartje ;
Huijbregts, Klaas M. L. ;
van Marwijk, Harm W. J. ;
Beekman, Aartjan T. F. ;
van der Feltz-Cornelis, Christina M. ;
Hakkaart-van Roijen, Leona .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 79 (04) :316-323
[22]   Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial) [J].
Grochtdreis, Thomas ;
Zimmermann, Thomas ;
Puschmann, Egina ;
Porzelt, Sarah ;
Dams, Judith ;
Scherer, Martin ;
Koenig, Hans-Helmut .
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2017, 80 :67-75
[23]   Telephone coaching for the prevention of depression in depression in farmers: Results from a pragmatic from a pragmatic randomized controlled trial [J].
Thielecke, Janika ;
Buntrock, Claudia ;
Titzler, Ingrid ;
Braun, Lina ;
Freund, Johanna ;
Berking, Matthias ;
Baumeister, Harald ;
Ebert, David D. .
JOURNAL OF TELEMEDICINE AND TELECARE, 2024, 30 (06) :918-930
[24]   Osteopathic care for low back pain and neck pain: A cost-utility analysis [J].
Verhaeghe, N. ;
Schepers, J. ;
van Dun, P. ;
Annemans, L. .
COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 40 :207-213
[25]   Cost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care An Economic Evaluation Alongside a 12-Month Randomized Controlled Trial [J].
Luciano, Juan V. ;
Sabes-Figuera, Ramon ;
Cardenosa, Eugenia ;
Penarrubia-Maria, Maria T. ;
Fernandez-Vergel, Rita ;
Garcia-Campayo, Javier ;
Knapp, Martin ;
Serrano-Blanco, Antoni .
CLINICAL JOURNAL OF PAIN, 2013, 29 (08) :702-711
[26]   Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care [J].
Stol, Daphne M. ;
Over, Eelco A. B. ;
Badenbroek, Ilse F. ;
Hollander, Monika ;
Nielen, Mark M. J. ;
Kraaijenhagen, Roderik A. ;
Schellevis, Francois G. ;
de Wit, Niek J. ;
de Wit, G. Ardine .
BMC MEDICINE, 2021, 19 (01)
[27]   Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care [J].
Daphne M. Stol ;
Eelco A. B. Over ;
Ilse F. Badenbroek ;
Monika Hollander ;
Mark M. J. Nielen ;
Roderik A. Kraaijenhagen ;
François G. Schellevis ;
Niek J. de Wit ;
G. Ardine de Wit .
BMC Medicine, 19
[28]   Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmacia(R)) [J].
Costa, Suzete ;
Guerreiro, Jose ;
Teixeira, Ines ;
Helling, Dennis K. ;
Pereira, Joao ;
Mateus, Ceu .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[29]   Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic [J].
Donna Patricia Manca ;
Carolina Fernandes ;
Aisha Lofters ;
Kris Aubrey-Bassler ;
Melissa Shea-Budgell ;
Denise Campbell-Scherer ;
Nicolette Sopcak ;
Christopher Meaney ;
Rahim Moineddin ;
Kerry McBrien ;
Paul Krueger ;
Tracy Wong ;
Eva Grunfeld .
BMC Primary Care, 24
[30]   Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic [J].
Manca, Donna Patricia ;
Fernandes, Carolina ;
Lofters, Aisha ;
Aubrey-Bassler, Kris ;
Shea-Budgell, Melissa ;
Campbell-Scherer, Denise ;
Sopcak, Nicolette ;
Meaney, Christopher ;
Moineddin, Rahim ;
Mcbrien, Kerry ;
Krueger, Paul ;
Wong, Tracy ;
Grunfeld, Eva .
BMC PRIMARY CARE, 2023, 24 (01)